Baird Financial Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.11M Buy
21,202
+7,327
+53% +$956K ﹤0.01% 1025
2025
Q4
$1.69M Sell
13,875
-6,994
-34% -$878K ﹤0.01% 1094
2025
Q3
$2.34M Buy
20,869
+397
+2% +$46.5K ﹤0.01% 992
2025
Q2
$2.74M Buy
+20,472
New +$2.25M ﹤0.01% 916

Other funds holding TMDX

Baird Financial Group's TMDX Position: Q1 2026 in Review

Baird Financial Group increased its Transmedics (TMDX) stake by 53% in Q1 2026, buying an estimated $956K and bringing the position to 21,202 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1025.

Baird Financial Group first reported a position in TMDX in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.74M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Baird Financial Group held 21,202 shares of Transmedics worth $2.11M as of Q1 2026.
  • Baird Financial Group bought 7,327 Transmedics shares in Q1 2026, an estimated $956K.
  • Transmedics made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1025 holding.
  • Baird Financial Group first reported a position in Transmedics in Q2 2025 and has held it in 4 quarters since.
  • Baird Financial Group's Transmedics position peaked at $2.74M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.